Skip to main content
European Commission logo
Enterprise Europe Network

Simplifying Digital Health: German Start-Up Advises DTX (Digital Therapeutics) Manufacturers on Market Entry in Germany and Helps Healthcare Facilities and Health Insurers to Find Suitable DTXs on the German Market

Summary

Profile Type
  • Business Offer
POD Reference
BODE20250627022
Term of Validity
11 July 2025 - 11 July 2026
Company's Country
  • Germany
Type of partnership
  • Commercial agreement
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
The company uses its in-depth market knowledge in Germany to facilitate international cooperations. The scientifically intensively tested German DTX are interesting for healthcare providers in countries with a shortage of personnel in the healthcare sector. Additionally, there is growing demand from patients worldwide for digital solutions that enable them to take responsibility for their own health.
Full Description
The German start-up based in Lower-Saxony supports cooperations in the digital healthcare sector.
Firstly, it advises DTX (Digital Therapeutics) manufacturers that would like to enter the German market. There are three main ways to be remunerated: through contracts with individual health insurance companies, through the DiGA fast track, and through the self-payer market. The various options are examined with the DTX manufacturer on a case-by-case basis, depending on the product. Support is also provided for subsequent steps, such as contacting German health insurance companies.
Secondly, they advise healthcare facilities or health insurers abroad who would like to use a scientifically evaluated German DTX and identify suitable products. They establish contact and provide support in establishing the business relationship through to the conclusion of the contract.
Advantages and Innovations
Cooperation partners can benefit from their many years of experience as medical management consultants in the healthcare sector. In addition, the start-up, founded in 2021, provides DTX / DiGA manufacturers in Germany with services for their market access. As a result, they know the DTX landscape in Germany and the reimbursement options inside out.
Stage of Development
  • Already on the market
Sustainable Development Goals
  • Goal 3: Good Health and Well-being
IPR status
  • No IPR applied

Partner Sought

Expected Role of a Partner
They seek partners who:
1) have developed a digital therapeutic product in their local market and are looking to expand into the German market. For these partners, they offer expert consulting to identify the most promising market entry strategies and provide hands-on support throughout the process.

or

2) are looking for digital health solutions from Germany for implementation in their local markets. For these partners they identify suitable DTX companies, facilitate the business partnership, and support the adoption of the solution to the target market.
Type and Size of Partner
  • R&D Institution
  • SME 11-49
  • University
  • SME 50 - 249
  • SME <=10
  • Big company
Type of partnership
  • Commercial agreement

Dissemination

Technology keywords
  • 01004001 - Applications for Health
  • 06001003 - Cytology, Cancerology, Oncology
  • 06001020 - Physiotherapy, Orthopaedic Technology
  • 06001011 - Heart and blood circulation illnesses
  • 06001008 - Environmental Medicine, Social Medicine, Sports Medicine
Market keywords
  • 09003007 - Other services (not elsewhere classified)
Targeted countries
  • All countries